A great experience and fantastic discussion. Thanks for the opportunity!

Episode 31! We talk about non-invasive versus invasive blood pressure monitoring from an observational paper by Haber et al from MedStar Washington Hospital Center Pulm/Crit Care and supplement that discussion with the 65 trial and discuss MAP targets (and how little we know about them!)

pod.link/1667336877

Episode 30! We recap the SCCM conference THEN discuss PROPHY-VAP from The Lancet Respiratory Medicine by Prof Dahyot-Fizelier. FINALLY we answer listener questions
(and apologies if we butchered some biochemistry in the process...)

PROPHY-VAP: pubmed.ncbi.nlm.nih.gov/38262428/

pod.link/1667336877

What a great listen, this discussion probably comes closest to the actual questions we turned over in the design process. And obviously, Joanna Stollings is a legend.

Episode 29! We compare the ATS and ESICM guidelines on ARDS management! There are some subtle but key differences and we talk about why that is and where we stand.

pod.link/1667336877

ATS: pubmed.ncbi.nlm.nih.gov/38032683/
ESICM: pubmed.ncbi.nlm.nih.gov/37326646/

This is a fun episode!

A little surreal, I definitely leaned on these summaries as a busy trainee (and as an attending). Now the ACORN trial has one. Bravo, thanks for the hard work!

Episode 28! Starting the year off with a big ECMO discussion talking about PRONECMO published last month in JAMA and then EOLIA as our old article published 2018 in NEJM

pod.link/1667336877

PRONECMO: pubmed.ncbi.nlm.nih.gov/38038395/
EOLIA: pubmed.ncbi.nlm.nih.gov/29791822/

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial - Edward Qian Todd Rice & colleagues jamanetwork.com/journals/jama/…

One of our 🔥Top Viewed at JAMA in 2023🔥

Read more “Best of…” here jamanetwork.com/journals/jama/…

One of the hardest things we do in critical care is deciding when to intubate. And even harder, is deciding when not to intubate. Awesome discussion on new study and data on a critical topic for critical care medicine.

Glad to get a chance to talk about this one!

This was a fun one, a good one where putting the paper into the context of other trials helps. Also highlights that even if you try, all trials have subtle differences that you need to take into account! We try to help you do that in this episode!

Episode 24! We continue talking about ESICM with all the COVID trials. We focus more on general takeaways and things we can carry to the future than COVID itself because COVID is decreasing in prevalence (and hopefully continues to decrease)

Find us: pod.link/1667336877

Episode 23! So many articles dropped with ESICM so we start wading through them with AMIKINHAL published in NEJM and then STRESS-L published in JAMA

AMIKINHAL: pubmed.ncbi.nlm.nih.gov/37888914/
STRESS-L: pubmed.ncbi.nlm.nih.gov/37877587/

Find us: pod.link/1667336877

The ACORN Study found that Piperacillin-Tazobactam does not increase the risk of acute kidney injury compared with Cefepime. Congratulations to Edward Qian et al for their recent publication in JAMA ! tinyurl.com/3eepcvah

Most viewed in JAMA in last 7 days?

1️⃣-2nd week in a row

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: ACORN RCT Edward Qian Todd Rice et al jamanetwork.com/journals/jama/…

Presented #IDWeek IDSA

Editorial jamanetwork.com/journals/jama/…

#criticalcare

Episode 22! Join us as we talk about Peripheral Pressors, a prospective observational study published in CHEST August 2023 and then hop back in the time machine for the MIDAS study published in Intensive Care Medicine in 2020!

Find us: pod.link/1667336877

Dr Edward Qian Edward Qian presents in the ESICM Opening President’s Session #LIVES2023 the results of ACORN published last week in JAMA JAMA

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial

The President's session: Clinical trials in Intensive Care is starting in Gold Room with Elie Azoulay, Jan De Waele MD, Alexander Vlaar, Giuseppe Citerio, Paul Young, Edward Qian, Ricard Ferrer, ᒪᗩᖇᗩ ᑭᖇIᔕᑕO

Join this session for some cutting edge science!

#LIVES2023

The LHS Platform is delighted to welcome Edward Qian to our steering committee! His expertise as an intensivist and in clinical informatics will be of great value in advancing the LHS Platform.